NCT07647354
Mako-MORE Registry
Not Yet Recruiting
Not specifiedAges 18+ObservationalStryker Orthopaedics
~950 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Mako Robotic-Arm Assisted Arthroplasty
At a glance
Recruiting sites
0 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Implant Survivorship at 2 Years Postoperative
Measured over 2-years postoperative
Conditions
Where it's being run
5 sites across 5 statesFlorida1
Kentucky1
New York1
Ohio1
Rhode Island1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
The subject is skeletally mature, and ≥ 18 years old.
The Subject has signed and dated an IRB/EC approved, study specific Informed Patient Consent Form (ICF).
The subject is scheduled to undergo manual arthroplasty or Mako Robotic-Arm Assisted Arthroplasty according to IFU.
The subject is willing and able to comply with postoperative scheduled clinical evaluations.
Exclusion
The subject is not able to express his/her consent as deemed by the investigator.
The subject is not able to fulfill a self-assessment questionnaire or follow-up visits as deemed by the investigator.
The subject is a prisoner.
Per surgeon discretion the subject is not a candidate for the study.
The subject is pregnant or breastfeeding.
What this trial measures
- Implant Survivorship at 2 Years Postoperative2-years postoperative
To evaluate survival rate at 2-years postoperative for Stryker devices implanted with the Mako Robotic-Arm Assisted System. Survival is defined as the absence of revision for implanted devices.